Stevanato Group SpA (MEX:STVN N) Interest Expense (Positive)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:STVN N Stevanato Group SpA MEX:STVN N
86 GF Score
Price MXN246.00
GF Value MXN315.25
! 6 Warning Signs
View Full Analysis

What is Stevanato Group SpA Interest Expense (Positive)?

Interest Expense (Positive) only applies to insurance companies.

MEX:STVN N
86GF Score
Stevanato Group SpA MEX:STVN N
Interest Expense (Positive) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Stevanato Group SpA (MEX:STVN N) Overvalued in 2026?

Based on GuruFocus' analysis, Stevanato Group SpA stock appears to be undervalued. The current stock price of MXN246.00 is trading 22% below its estimated GF Value™ of MXN315.25.

Key valuation signals for MEX:STVN N:

  • Interest Expense (Positive):
  • GF Value™: MXN315.25 vs. price of MXN246.00 (22% below fair value)
  • GF Score™: 86/100 with 6 warning signs

No single metric tells the full story. See the MEX:STVN N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stevanato Group SpA Business Description

Other Exchanges STVN:USA87N:Germany
Address Via Molinella 17, Piombino Dese, Padua, ITA, 35017
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
86GF Score

Get the complete analysis for MEX:STVN N

Interest Expense (Positive) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN246.00
Price
MXN315.25
GF Value